AKT1 and prostate cancer: We created a map of the KEGG prostate cancer pathway (entry hsa05215) and identified controlled proteins, finding drugs that could potentially affect phosphatidylinositol 3-kinase (PI3K; insulin sensitivity), glycogen synthase kinase-3 (GSK3; glycogenesis), and AKT (insulin sensitivity).